Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

NCT01982552 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01982552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01982552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
January 31, 2014
Enrollment
147 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris